Skip to content
Boca Raton City Online – Lifestyle
Author:
Acrivon Therapeutics, Inc
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
March 7, 2026
Acrivon Therapeutics Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory
March 7, 2026
←
Previous Page
1
2